Continuous Selective Intra-Arterial Application of Nimodipine in Refractory Cerebral Vasospasm due to Aneurysmal Subarachnoid Hemorrhage

Table 3

ptiO2 before, 2 and 6 hours, and 1–5 days after starting continuous selective intra-arterial nimodipine infusion, ptiO2 (mmHg).

Case no.	ptiO2 before	ptiO2 at 2 hours	ptiO2 at 6 hours	ptiO2 day 1	ptiO2 day 2	ptiO2 day 3	ptiO2 day 4	ptiO2 day 5
1	9	21	20	15.4	10.9	4.3	3.7	0
2	4	20	19	19.2	19.4	14.3	4.8	2.9
3	14	22	23	19.3	21.5	22.3	22.4	0
4	14	27	26	23.4	23.5	0	0	0
5	15	29	26	26.3	26.8	24.2	27.9	0
6	9	18	17	17.5	18.3	12.2	0	0
7	11	14	16	16.3	17.2	17.5	0	0
8	6	15	16	14.2	9.3	4.2	0	0
9	12	19	22	22.3	24.8	24.7	0	0
10	10	18	17	17.9	18.0	0	0	0
11	14	22	25	23.4	22.9	22.6	0	0
12	5	16	17	14.3	14.9	7.9	6.6	0
13	8	20	22	23.6	22.8	22.0	0	0
16	13	21	24	22.4	21.8	22.9	0	0
18	5	18	19	21.1	18.3	18.6	0	0
21	11	20	19	19.3	20.4	18.3	0	0
22	8	18	18	19.5	17.3	0	0	0
23	10	23	22	24.7	24.4	28.7	30.5	29.3
24	14	20	22	20.3	12.3	9.8	0	0
27	14	21	21	22.3	19.5	0	0	0
28	14	25	24	24.3	24.0	25.6	0	0
29	7	17	16	16.9	18.3	16.2	0	0

ptiO2: partial tissue oxygenation; 0: no continuous selective intra-arterial nimodipine application.